To adapt a validated instrument that quantitatively measures stigma among English/ Swahili-speaking tuberculosis (TB) patients in Kenya, a high-burden TB country. Following ethical approval, we elicited feedback on the English-and Swahili-translated Stigma Scale for Chronic Illness (SSCI) tools through cognitive interviews. We assessed difficulties in translation, differences in meaning, TB contextual relevance, patients' acceptability to the questions, and issues in tool structure. The interviews were audiorecorded, transcribed, and translated. Open coding and thematic analysis of the data were conducted by 2 independent researchers. Between May and September 2015 We wish to acknowledge all the tuberculosis (TB) patients who participated in this study, the health workers who provided feedback for the adapted Stigma Scale for Chronic Illness for TB stigma at the 13 study sites, the National TB Program of Kenya, the Nairobi County Health Services Sector, Kenyatta National Hospital, Mbagathi District Hospital, Mama Lucy Kibaki Hospital, Mathari Hospital, Dandora I, Eastleigh, Kangemi, Langata, Makadara, Mukuru, Ngara, Prison Staff Training College, Waithaka Health Centre, University of Nairobi, University of Washington, International AIDS Research Training Program, and all other individuals and institutions that provided support to the TB Kwisha Study.
we conducted a qualitative study among 20 adult TB patients attending 11 health facilities in Nairobi County, Kenya. Most questions were understood in both English and Swahili, deemed relevant in the context of TB, and acceptable to TB patients. Key areas of adaptation of the SSCI included adding questions addressing fear of infecting others and death, HIV stigma, and intimate, family, and workplace relationship contexts. Questions were revised for nonredundancy, specificity, and optimized sequence. The adapted 8-item SSCI appears to be a useful tool that may be administered by health workers in English or Swahili to quantify TB stigma among TB patients in Kenya.
Keywords: measuring stigma, TB, Nairobi, Kenya Supplemental materials: http://dx.doi.org/10.1037/sah0000056.supp In 2014, it was estimated that 9.6 million people fell ill with tuberculosis (TB) worldwide, 12% of whom were HIV-positive (World Health Organization, 2015) . The World Health Organization End TB Strategy, geared toward zero deaths, disease, and suffering due to TB globally, addresses TB-related stigma in all its three pillars (World Health Organization, 2013) , as it is a barrier to TB control with serious health and socioeconomic consequences (Christodoulou, 2011; Courtwright & Turner, 2010; Jaramillo, 1999; Van Brakel, 2006) . Weiss and Ramakrishna (2006) defined healthrelated stigma as "a social process or related personal experience characterized by exclusion, rejection, blame, or devaluation that results from experience or reasonable anticipation of an adverse social judgment about a person or group identified with a particular health problem" (p. 536). Drivers of stigma in TB include the fact that it is an infectious condition spread in the air and its association with HIV disease (Christodoulou, 2011; Courtwright & Turner, 2010; Daftary, 2012; Jaramillo, 1999; Kipp et al., 2011; Van Brakel, 2006) . The stigma process proposed by Watson, Corrigan, Larson, and Sells (2007) suggests that negative stereotype awareness, agreement and application, result in reduced selfesteem and self-efficacy. In the context of TB, patients with TB may experience discrimination (enacted stigma), become aware of the negative stereotype around TB (perceived stigma), then concur that the negative stereotype applies and internalize the stigma (self-stigma). Internalized stigma potentially results in TB patients not fully seeking TB care and avoiding cooperation in having their close contacts investigated for TB (Courtwright & Turner, 2010; Van Brakel, 2006) . In this way, TB stigma is not only detrimental to TB patients' health at an individual level but may also promote further spread and drug resistance (Christodoulou, 2011; Courtwright & Turner, 2010; Jaramillo, 1999; Somma et al., 2008; Van Brakel, 2006) .
Validated tools to quantitatively measure stigma in TB patients are scarce (Macq, Solis, & Martinez, 2006; Van Rie et al., 2008) and challenges in TB-related stigma tool development include the inability to capture all the feelings of TB patients (Macq, Solis, Martinez, & Martiny, 2008) , and the varying cultural and TB/HIV epidemiological contexts in which they are utilized (Courtwright & Turner, 2010; Kipp et al., 2011; Macq et al., 2008 ). An instrument that comprehensively measures stigma among TB patients in Kenya, a high-burden TB/HIV country with a low prevalence of multidrug resistance TB (World Health Organization, 2015) , is envisioned in the national strategic plan (Kenya Ministry of Health, 2014), but does not currently exist. Adaptation of an existing validated stigma tool to assess TBrelated stigma in this context would be a first step. The 26-item Stigma Scale for Chronic Illness (SSCI) developed by Rao et al. is a tool for evaluating the stigma of people with chronic illnesses designed for self-administration in the English language (Rao et al., 2009; Rao, Molina, Lambert, & Cohn, in press ). We sought to adapt a validated instrument that quantitatively measures stigma among English/Swahili-speaking TB patients in a high-burden TB setting in Africa.
Method Ethics Statement
We obtained ethical approval from the Kenyatta National Hospital/University of Nairobi Ethics Research Committee and the University of Washington institutional review board.
Research Team and Reflexivity
After obtaining ethical approval, Diana Marangu, a female Kenyan pediatrician with formal training and experience in qualitative research, conducted the cognitive interviews without establishing a relationship with participants prior to study commencement. Hannah Mwaniki, a female, Kenyan anthropologist with extensive training and experience in qualitative research, transcribed and translated the audio recordings. These two researchers analyzed the data independently and where consensus was not reached, Salome Nduku, a female Swahili/ English translator and communicator with over 10 years of experience in translation and localization, served as the tie breaker. The three independent multilingual researchers independently translated the original SSCI into Swahili and back into English and adapted it for health worker (HW) administration. Other members of the research team included senior researchers with extensive experience in the fields of stigma, qualitative research, TB-HIV, and health economics.
Participant Selection
We selected study participants through a multistage sampling approach restricted to public health facilities in Nairobi County, a densely populated urban metropolis and the capital of Kenya. This comprised 13 TB clinics stratified by the level of health care provided: Kenyatta National Hospital, a tertiary referral facility; Mbagathi District Hospital, Mama Lucy Kibaki Hospital, and Mathari Hospital, secondary referral facilities; and one primary health facility randomly sampled from each of the nine subcounties in Nairobi County. We obtained ethical approval to interview 20 participants, a sample size suggested in the literature to be sufficient to reach data saturation in a qualitative study such as ours with a narrow scope, specific sample, and established theoretical framework (Morse, 2015) , among other factors that contribute to adequate information power (Malterud, Siersma, & Guassora, 2015) . Participants were eligible if they were ages Ն18 years, had clinician-diagnosed TB, and were attending the selected TB clinics. We approached participants, sought informed consent, and conducted faceto-face interviews at each selected TB clinic during hours of operation. Our goal was to achieve a representative sample with regard to the level of health facility (primary, secondary, and tertiary) and subcounty distribution in Nairobi County.
The Stigma Scale for Chronic Illness (SSCI)
The original 26-item SSCI is made up of 13 items that measure internalized stigma, 11 items that measure enacted stigma, and 2 items that address disclosure concerns as a result of disease-related manifestations. It is also referred to as the Neuro-Qol (Northwestern University, Health Measures, 2016) Stigma Scale and is available in Spanish, simplified Chinese, and Korean translations of the English version ("Neuro QoL").
Data Collection Process
No one else was present during data collection besides the participants and lead researcher, who used a cognitive interview guide, and continually revised the tool through an iterative process to incorporate TB patients' suggestions (Willis, 2005 ; online supplemental Table 1 ). The researcher audio recorded the interviews, took field notes, and noted when data were saturated. The interviews were translated into English and transcribed verbatim. We did not repeat interviews or return transcripts to participants for comments or correction. To maintain confidentiality, we did not audio record participant names during interviews. We stored data in password-protected files with access restricted to researchers, and destroyed audiorecorded files 6 months after transcription as per our protocol.
Analyses
Two independent researchers identified themes related to SSCI tool adaptation in advance. These included difficulties in translation, differences in meaning, TB contextual relevance, acceptability of the questions to patients, and issues in tool structure. The researchers derived subthemes related to stigma in the context of TB in English/Swahili-speaking patients in Nairobi from the data and categorized them as factors promoting TB stigma, factors reducing stigma, and time. They manually coded the transcripts and also used Atlas.ti GmbH, Berlin version 7.5.10 (student license) to manage the data. After analysis, we received and incorporated feedback on the tool from HWs.
Results

Patient Characteristics
We interviewed 20 adult TB patients attending the study TB clinics between May and September 2015 sampled from 11 of the 13 selected health facilities in Nairobi County, Kenya. Of the 20 adults, most were male with a majority having completed primary education. Half of the participants responded in mixed Swahili and English, whereas few responded in Swahili or in English. Most participants had disclosed their TB status to at least one person, and attended primary health facilities. The median age was 32.5 years (interquartile range [IQR] 29.0 -37.5), with youngest and oldest interviewees being 23 and 47 years, respectively. Median time since TB diagnosis was 2 months (IQR 1.0 -3.5), and median interview duration was 32.5 min (IQR 21.5-47.5). Three TB patients refused to participate, two because of a busy schedule and one feeling uncomfortable being involved in research (see Table 1 ).
Translation and Meaning of the Questions
Generally, we did not note difficulties in the translation of individual words from English to Swahili, except in one interview in which two errors were made in Questions 20 and 21 which influenced the meaning of the question [Interview 2] .
TB patients understood most questions well but in a few interviews we noted differences in meaning between the patient and the researcher. Patients initially interpreted "looking at you" in Question 8 -"Do you think that because you have TB, people avoided looking at you?"-in Swahili to mean looking after you [Interviews 6, 10, 14, 16, 18, and 20] . The word kuangalia in Swahili has two meanings, to look at and to look after. We provided further clarity to enable the patient to understand the question during the interview process. We also adjusted the question in the final harmonized Swahili SSCI to "kukuangialia usoni/machoni" -"to look at you in the face/eye"-to make this distinction.
Another Swahili word with two meanings is rafiki, which in this context could mean a general friend or a romantic friend, was used in Question 22-"Do you think that because you have TB, you avoided making new friends?"-and some TB patients explicitly requested a distinction [Interviews 16 and 18] . We learned from other interviews that the context of relationships was an important aspect in TB stigma. We distinguished that various levels of relationships were necessary, particularly general and romantic relationships. Patients occasionally misinterpreted "physical limitation" in Question 17-"Do you think that because you have TB, you felt embarrassed because of your physical limitations?"-for "weight loss" [Interviews 5, 12, and 14] . In the final harmonized SSCI tool, the question was revised to provide situations in which one would be limited physically-at home/school/work. Participants initially misinterpreted "felt left out of things" in Question 4 -"Do you think that because you have TB, you felt left out of things?"-in Swahili to mean "felt left behind" [Interviews 1 and 13]. For clarity we added an option in Swahili backtranslated into English as "you have felt excluded from things." We also noted the initial meaning of Question 10 -"Do you think that because you have TB, you worried about other people's attitudes towards you?"-to be difficult to understand [Interview 1].
Relevance of Questions in the Context of Tuberculosis
Most of the patients deemed all 26 questions in the SSCI tool to be relevant in the context of TB. Although responses to each question varied from patient to patient, TB patients provided rich and diverse perspectives which clearly depicted that the questions were applicable to TB stigma.
Question 18 -"Do you think that because you have TB, you felt embarrassed about your speech?"-was one such question. While patients could hardly see a relationship between TB and speech, others viewed the question in the context of their appearance. Some TB patients cited personal experiences where they felt embarrassed about how they appeared when they talked, particularly when coughing uncontrollably, coughing blood, or panting due to breathlessness. Other patients felt embar-rassed because people would judge the content of their speech and ignore their points because they suffered from TB. We noted that this question was not very specific and omitted it in the final adapted SSCI for TB stigma, but retained the question on appearance, which was the context in which most TB patients responded to this question.
Another question with differing responses was Question 13: "Do you think that because you have TB, it was hard to stay neat and clean?" Although possible, some TB patients felt that being dirty and disorganized was just an excuse when one had TB, whereas others could consider situations when this could apply, and even relate to situations where they were too sick from TB to bathe or stay clean. Nonetheless, most TB patients responded that for them it was not hard to stay neat and clean. We noted that TB severity and substance abuse may influence the ability of TB patients to perform tasks which require support from caregivers, and thus considered them important patient variables to collect. Similar to Question 18, we omitted this question but added a question on support from family, friends, coworkers/schoolmates, or employers, as this was connected and emerged as a major theme.
Question 9 -"Do you think that because you have TB, strangers tended to stare at you?"-also elicited differing responses. Some TB patients brought out an important aspect of disclosure: Strangers did not know they had TB, so why would they stare? Patients, especially those with physically apparent symptoms, agreed that strangers tended to stare at them, whereas TB patients who did not have distinctive signs of illness could not understand this question since they had no tell-tale signs. We also omitted this question but recognized the importance of collecting data on disclosure/TB signs and retaining the question on appearance. We classified the emerging major themes related to TB stigma in this context under three intertwined categories: factors promoting TB stigma, factors reducing stigma, and time which formed the basis of the eight-item adapted SSCI for TB stigma (Figures 1 and 2 , Tables 2-4, and online supplemental Table 2 ).
Factors promoting TB stigma. One of the main factors promoting TB stigma was fear of infecting others or experiencing exclusion by others in the community for fear of getting infected. TB patients reported that they would stay away from others including their intimate partners for fear of infecting them. The reason they were running from me is [because] there is a day I coughed blood. I was at home, at my mother's place. Now on coughing blood, my brother saw. He gave an order that even food, when I go there, I be given with my plate and it is put aside. When I come, I am given [food] with it [that plate]. . . . The cup itself that they put tea for me, is thrown in the toilet.
TB patients also reported the lack of support from members of the community including family, friends, coworkers, and employers as a factor promoting stigma. Patients expressed that it was more painful when they experienced stigma from relationships that they regarded to be close such as intimate and family relation- ships. [Interview 3]: "So I wonder: What is the reason that is keeping her (my sister) away from me? Is it the fear that maybe she has helped me and now she is tired or is she scared that she will get infected?" [Interview 12]:
[Some people can seem uncomfortable with me.] Yes it can happen with close people. And they can take you as an outcast or something like a taboo and say that TB is a bad disease, that you have brought shame. It depends on the understanding. So close people, that can be family members, it can be a relationship partner and sometimes family members, make it more painful. Their attachment is too close, they are the ones you rely on for confidence, for courage. So if it becomes negative to them, and they treat you in some other way, it will stress you.
Other factors promoting TB stigma identified were fears or worries related to TB outcomes including changes in appearance, lengthy treatment duration, drug side effects, and death. Disclosure of TB status was mainly influenced by HIV stigma and the nature of the friendship. TB patients reported that it was difficult to disclose their TB status as community members immediately assumed that they were HIV coinfected. TB patients' disclosure of their TB status was easier if they considered the nature of the relationship to be close. [Interview 9]: "Even telling people right now, somebody who is not a close friend or maybe can be a friend, that I have TB is not easy, because I feel embarrassed. I feel bad. It is a bad disease. It is like HIV." However, patients reported that they found it difficult to disclose their TB status to their intimate partners, despite this being considered a close relationship. Figure 2. Internalized, perceived, and enacted TB stigma in relation to time. TB ϭ tuberculosis. Table 2 Interview Characteristics (N Note. Q4 meaning (left out of things)-Interviews 1 and 13 in Swahili; Q6 sensitivity (make fun of)-Interviews 5, 6, 7, and 9 in English and Swahili; Q8 meaning (kuangalia has two meanings: "to look at" and "to look after"; requires clarity)- Figure 1A) Factors reducing TB stigma. We identified health worker support through health education as one of the main factors decreasing TB stigma. In addition, TB patients also reported that belief in God influenced their self-efficacy. Relationship support from family, friends (including peers/friends who had experienced TB), coworkers, and employers which could be physical, financial, emotional, or spiritual, and nondisclosure of TB status decreased TB stigma. The overall underlying factor reducing TB stigma was a proper understanding of TB by No. According to the TB patients, the closer the relationship, the more it hurt if there was lack of support. Similar to distinguishing the various forms of support, TB patients also distinguished the various types of relationships which fell into five general categories focusing on intimate, family, and workplace relationships. The most extreme form of lack of support in a relationship was rejection/abandonment, or being fired from work.
26-item SSCI
• Nilikuwa na wasiwasi kwamba nilikuwa mzigo kwa wengine.
[ ‫ء‬ Did you worry that you were a burden to others? (Ulikuwa na wasiwasi kwamba ulikuwa mzigo kwa wengine?)] So they [close people, that can be family members, it can be a relationship partner and sometimes family members] have to be happy with you and they also have to understand the disease. They make it lighter for you and say 'Yes, that is a small thing. That is not a big thing.' TB nowadays is another small thing, not like the other days. So you have to get people who are . . . a strong foundation and people who are close to you.
( Figure 1B) Internalized/perceived TB stigma and enacted stigma in relation to time. TB stigma appeared to change based on time between diagnosis and treatment. Initially patients reported both internalized and perceived TB stigma especially prior to health education/ treatment. Patients who had commenced treatment and noted clinical improvement tended to be more positive, with reduction in internalized/perceived stigma with time on TB treatment. [Interview 12]:
It was a series of thoughts [that came to my mind in the last two months with TB]. There were first thoughts, and they were too many thoughts. And they kept on reducing. And right now there are some thoughts also. At first, there were some thoughts that were negative: That I can lose my health at any time; TB is a disease that is so severe; and TB is a disease that you have to be treated for a very long time, and if you don't take care of yourself very carefully, the treatment can backfire. So it made me get some phobia myself, but I controlled some thoughts after some help from the nurses here, and I got some awareness. And through taking the treatment, it happened for itself. It is not that I was given the awareness, it happened for itself. The drugs were working in the body and then right now, those thoughts are not there. Now they are transformed to be positive.
Conversely, patients who reported persistent symptoms despite treatment tended to be negative. [Interview 10]:
I am not far from people. Apart from now I have told you this disease, it is like, I think as if am doing zero work of using medication. Sometimes I feel pain because my children are small, so it is bad if there is no work that these medicines are doing. Because let us say I can leave my children, that is the only thing that is making me feel different. I continue using these medications and am not getting well. That is the only thing that makes me feel distant from people. It is increasing, so I think I might die, yet am using medication. But if this disease can be treated and I continue getting well and I improve, I cannot feel distant from people. I feel distant from people because of only that; am using Participants tended to disclose their TB status more over time, and if they shared their diagnoses with negative individuals, they experienced more enacted stigma. Similarly, less/no disclosure resulted in less/no enacted stigma. TB patients with manifest signs for example, persistent cough, hemoptysis, or weight loss, experienced enacted stigma much earlier even without disclosure of their TB status, and the enacted stigma decreased with time on TB treatment as the patient improved (see Figure 2) .
Issues in Tool Structure
From TB patients' responses during the cognitive interviews, we noted redundancy and suboptimal flow in the questions. Although we had a very narrow scope that is, the 26-item SSCI, one of the patients suggested that we might gain richer responses if we simply asked about the thoughts of TB patients. Other participants reiterated that TB patients wanted to be listened to [Interviews 10, 12, and 16] . After introducing this open question first and reordering the questions for optimal flow, the interviews enabled us to go deeper into TB stigma while still focusing on the 26 items of the SSCI. The duration of responses to this open question ranged from 1 to 13 min.
With regard to content, one TB patient pointed out explicitly that there was no specific question on the various levels of relationships including family, friends, coworkers, and employers and suggested this addition [Interview 4] . This TB patient's observation further solidified our decision to include this dimension as we found that support from various relationships was an important subtheme of TB stigma that emerged from our data. Another TB patient suggested that we include a question on TB treatment and outcomes. From the data, components that were brought up included treatment adherence, drug side effects, cure/recovery, noncure/nonrecovery, and death. The most common aspects that were discussed by the patients with regard to TB stigma were worry of not recovering and other people assuming they would die. We incorporated these latter two in the eight-item adapted SSCI, and included an "other, specify" section for additional thoughts, worries, or fears of TB patients.
We explored response option preferences in eight interviews, asking TB patients to choose between a 5-point and a 3-point Likert scale of frequency of experiences ranging from never to always. Four of eight patients preferred the 3-point Likert scale for its simplicity and brevity, especially because "people had other things to do, like go to work." Two out of eight patients preferred the 5-point Likert scale because it provided more options. One patient was ambivalent and another felt that this scale restricted her responses. Although most of these TB patients understood both Swahili and English, some felt the rating in English was simpler. All TB patients whom we asked found it easier to point on a chart than to have the options committed to memory or the health worker repeating the options after each question.
Patients' Acceptability to the Questions
Most TB patients liked these questions and made it quite clear that they want to be listened to. They found the questions acceptable, relevant, and helpful because they reduced the fear and provided a sense of relief and hope through unburdening. We questioned the influence of positionality of the interviewer being a health worker when some patients stated that all the questions were good and "you are a doctor." Despite this concern, we were encouraged that some TB patients were confident in stating which questions they found "sensitive."
Four TB patients did not find Question 6 acceptable: "Do you think that because you have TB, people made fun of you?" These patients were alarmed at how someone would make fun of one who was sick. "They cannot make fun of me because it is a disease which is not your faul." [Interview 15] . Some patients could relate to the superficial and deeper meanings of making fun of TB patients. For example, there were TB patients who were told by their coworkers/friends, "Unadedi/Unaenda," Swahili slang to jokingly mean "you are dying" [Interviews 9 and 20]. For others, the jokes were around wasting/weight loss. Although this question was omitted, questions relating to fear of death and appearance were retained.
One TB patient found Question 20, "Do you think that because you have TB, you will blame yourself?" and Question 21, "Do you think that because you have TB, you will not make friends?" to be sensitive [Interview 15 ]. These two questions were omitted, but related questions were retained: TB patients worrying about being a burden to others, and lack of support from friends leading to possible rejection/loss of friends.
Discussion
To the best of our knowledge, this is the first study globally to adapt the SSCI for TB-related stigma, and also adapt a tool to measure stigma for English/Swahili-speaking patients with TB particularly in an urban context in sub-Saharan Africa. From the literature we identified three tools that quantitatively measure TB stigma: the 10-item tool adapted by Macq et al. in Nicaragua from the Internalized Stigma for Mental Illness (ISMI) scale by Ritsher et al. (Macq et al., 2006 (Macq et al., , 2008 ; the TB and AIDS Scale developed by Van Rie et al. in Thailand with three scales: 12-item experienced TB stigma scale, 11-item perceived TB stigma scale, and a 10-item perceived AIDS scale (Kipp et al., 2011; Van Rie et al., 2008) ; and a 5-item scale developed by Chowdhury et al. in Bangladesh to measure enacted TB stigma (Chowdhury, Rahman, Mondal, Sayem, & Billah, 2015) . The eight-item adapted SSCI for TB stigma we propose for the assessment of TB stigma in Nairobi is consistent with the scales previously developed in three domains. It measures perceived and enacted TB stigma as do the Macq, Van Rie, and Chowdhury tools; internalized TB stigma as does the tool by Macq et al.; and HIV perceived stigma in the context of TB disease as does the Van Rie tool. The specific eight items in our adapted scale center around fear of infecting others and death/nonrecovery; feeling like a burden; lack of support from intimate/ family/workplace relationships (Dias, de Oliveira, Turato, & de Figueiredo, 2013) ; and HIV stigma consistent with the literature (Chang & Cataldo, 2014; Courtwright & Turner, 2010; Van Rie et al., 2008; Wynne et al., 2014) . To obtain a broader spectrum of responses, we propose to use the 5-point Likert scale ranging from rarely to always and plan to formally test this tool's usability in a larger upcoming study.
In our analysis, time was a major emergent theme that influenced internalized, perceived, and enacted stigma in different ways, thus necessitating measuring TB stigma at baseline and at different time points, as ideal time points and references may not be known. In an interventional study in Nicaragua, Macq et al. (2008) assessed TB stigma at 15 days and at 2 months since starting TB treatment, but temporal changes in internalized, perceived, and enacted stigma within TB patients were not reported. Other reference points to time apart from commencement of TB treatment may include diagnosis, health education provision, and disclosure. Additional covariates noted to potentially influence TB stigma in our context and were consistent with other studies included: age; gender; level of education (Courtwright & Turner, 2010) ; religion; income; TB knowledge on the cause, transmission, and cure; knowing a person with TB; HIV status; and TB symptoms (Kipp et al., 2011) .
The strength of our adapted tool lies in allowing for qualitative and quantitative assessment of TB stigma gleaned from TB patients in this context. Approaching TB stigma from an individual perspective and not just the public health one is imperative (Somma et al., 2008) . Although it has been documented that no tool can be exhaustive regarding TB stigma (Courtwright & Turner, 2010) , we think that beginning with an open question inquiring about the thoughts/worries/fears of TB the patient in the eight-item adapted SSCI for TB stigma may help capture aspects of TB stigma that are important to each TB patient. In the future, our eight-item adapted SSCI designed to measure TB stigma may be utilized to test the effectiveness of TB stigma interventions, similar to the adapted ISMI by Macq et al. (2008) .
Additionally, this is the first study to elaborately translate the original English-language 26-item SSCI into Swahili through a process of iteration by a multidisciplinary team incorporating feedback from English/ Swahili-speaking patients. English and Swahili are the two dominant languages spoken by most Kenyans. While English is the language of instruction in all educational institutions, Swahili is the language of daily interactions with people of different ethnic backgrounds in Kenya and is widely spoken in eastern and central Africa (Abuom & Bas-tiaanse, 2012) . The translated SSCIs may be useful for researchers conducting stigma studies related to chronic illness in English/ Swahili-speaking populations in the future (online supplemental Table 2 ).
TB awareness in Nairobi County is almost universal and approximately 90% of both the women and men who are aware of TB know that TB is spread in the air by coughing (Kenya National Bureau of Statistics, 2016). It was therefore unsurprising to find that most participants knew that TB is spread in the air by coughing; however, TB patients and their communities also harbored incorrect notions of TB transmission. The Kenya Demographic and Health Survey did not report on the proportion of those who also mentioned incorrect routes of TB transmission (Kenya National Bureau of Statistics, 2016.). Our team identified potential areas for TB patient empowerment that may be pertinent in averting TB stigma including knowledge on prevention despite infectiousness, cure despite deadliness, association with HIV in some but not all TB patients, anticipation of potential changes in appearance, and avoidance of negative feelings as the situation is temporary with proper treatment.
We envisage that HWs can utilize this onepage tool to elicit rapid feedback from TB patients; identify individual gaps that may promote TB stigma at a glance; and facilitate a conversation that will enable TB patients gain a proper understanding of TB. HWs are not limited to clinicians and nurses at the health facility, but also include social workers and community health workers who are very crucial cadres of HWs in TB care. We envision that this tool will be simple to administer and findings will be easily interpreted by HWs. The embedded action points based on the potential areas for TB patient empowerment we identified in this study could offer an opportunity for HWs to reinforce health education provided that it is specific to the gaps they will note. In addition, this tool may facilitate seamless follow-up among different HWs and potentially allow for audit of care provision related to TB stigma. Furthermore, this tool could be used for comparing TBrelated stigma across various health facilities for monitoring and evaluation purposes.
Since cognitive issues are dynamic, we propose that this tool be used at diagnosis prior to treatment commencement as a baseline, at the end of the first month, and thereafter monthly. This would assist HWs to consistently address stigma and reinforcing key messages tailored for each patient. These timings would align with routine TB follow-up visits, but may require to be individualized based on prior findings. Optimal timings for assessment could be piloted. The health workforce in many low-and middle-income countries is constrained, and additional tools could be considered burdensome. The tool's utility and implementation challenges will be evaluated in a planned future study. This proposed tool has the potential for global adaptability. Translation to common languages is necessary for utilization in varied contexts. In addition, it is important to recognize unique drivers of TB epidemiology in context such as HIV prevalence.
Positionality was a potential bias in this study likely reduced because the interviewer did not work in any of these TB clinics. We were not able to assess potential stigma promoted by HWs as the eight-item adapted SSCI is a HW-administered tool. Although self-administered tools are superior in this respect, this approach may not be pragmatic in the context of busy health facilities.
Conclusion
In conclusion, we successfully adapted an existing validated 26-item SSCI stigma assessment tool into a shorter, locally contextualized eight-item SSCI, which may be administered by HWs in English or Swahili to quantify stigma among TB patients in Kenya. We will assess its utility in quantifying TB stigma in a larger population in the next phase of this study.
